{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:39:16Z","timestamp":1787647156087,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12020-020-02401-6","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T08:02:36Z","timestamp":1593763356000},"page":"642-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0505-107X","authenticated-orcid":false,"given":"Daichi","family":"Miyaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Toi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"issue":"10116","key":"2401_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, L. Bandeira, A. Khan, N.E. Cusano, Hyperparathyroidism. Lancet 391(10116), 168\u2013178 (2018)","journal-title":"Lancet"},{"issue":"10","key":"2401_CR2","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561\u20133569 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2401_CR3","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1210\/jc.2009-2819","volume":"95","author":"B Wu","year":"2010","unstructured":"B. Wu, P.I. Haigh, R. Hwang, P.H. Ituarte, I.L. Liu, T.J. Hahn, M.W. Yeh, Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95(9), 4324\u20134330 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2401_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"B.C. Silva, W.D. Leslie, H. Resch, O. Lamy, O. Lesnyak, N. Binkley, E.V. McCloskey, J.A. Kanis, J.P. Bilezikian, Trabecular bone score: a noninvasive analytical method based upon the DXA image. J. Bone Miner. Res. 29(3), 518\u2013530 (2014)","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"2401_CR5","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/jbmr.499","volume":"26","author":"D Hans","year":"2011","unstructured":"D. Hans, A.L. Goertzen, M.A. Krieg, W.D. Leslie, Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J. Bone Miner. Res. 26(11), 2762\u20132769 (2011)","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"2401_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"C. Eller-Vainicher, M. Filopanti, S. Palmieri, F.M. Ulivieri, V. Morelli, V.V. Zhukouskaya, E. Cairoli, R. Pino, A. Naccarato, U. Verga, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 169(2), 155\u2013162 (2013)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2401_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","volume":"53","author":"E Romagnoli","year":"2013","unstructured":"E. Romagnoli, C. Cipriani, I. Nofroni, C. Castro, M. Angelozzi, A. Scarpiello, J. Pepe, D. Diacinti, S. Piemonte, V. Carnevale, S. Minisola, \u201cTrabecular Bone Score\u201d (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone. 53(1), 154\u2013159 (2013)","journal-title":"Bone."},{"issue":"10","key":"2401_CR8","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1210\/jc.2014-1417","volume":"99","author":"C Marcocci","year":"2014","unstructured":"C. Marcocci, J. Bollerslev, A.A. Khan, D.M. Shoback, Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(10), 3607\u20133618 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2401_CR9","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"M.A. Perazella, G.S. Markowitz, Bisphosphonate nephrotoxicity. Kidney Int. 74(11), 1385\u20131393 (2008)","journal-title":"Kidney Int."},{"issue":"11","key":"2401_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/M15-1232","volume":"164","author":"MW Yeh","year":"2016","unstructured":"M.W. Yeh, H. Zhou, A.L. Adams, P.H. Ituarte, N. Li, I.A. Liu, P.I. Haigh, The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study. Ann. Intern. Med. 164(11), 715\u2013723 (2016)","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"2401_CR11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jbmr.403","volume":"26","author":"SA Jamal","year":"2011","unstructured":"S.A. Jamal, O. Ljunggren, C. Stehman-Breen, S.R. Cummings, M.R. McClung, S. Goemaere, P.R. Ebeling, E. Franek, Y.C. Yang, O.I. Egbuna, S. Boonen, P.D. Miller, Effects of denosumab on fracture and bone mineral density by level of kidney function. J. Bone Miner. Res. 26(8), 1829\u20131835 (2011)","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"2401_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jgs.15250","volume":"66","author":"C Eller-Vainicher","year":"2018","unstructured":"C. Eller-Vainicher, S. Palmieri, E. Cairoli, G. Goggi, A. Scillitani, M. Arosio, A. Falchetti, I. Chiodini, Protective effect of denosumab on bone in older women with primary hyperparathyroidism. J. Am. Geriatr. Soc. 66(3), 518\u2013524 (2018)","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"2401_CR13","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00198-017-4140-y","volume":"28","author":"MR McClung","year":"2017","unstructured":"M.R. McClung, K. Lippuner, M.L. Brandi, J.R. Zanchetta, H.G. Bone, R. Chapurlat, D. Hans, A. Wang, C. Zapalowski, C. Libanati, Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporos. Int. 28(10), 2967\u20132973 (2017)","journal-title":"Osteoporos. Int"},{"issue":"8","key":"2401_CR14","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"E. Koumakis, J.C. Souberbielle, E. Sarfati, M. Meunier, E. Maury, E. Gallimard, D. Borderie, A. Kahan, C. Cormier, Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 98(8), 3213\u20133220 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"2401_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black, S.R. Cummings, Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984\u2013996 (1996)","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"2401_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1053\/j.ajkd.2007.09.004","volume":"50","author":"E Imai","year":"2007","unstructured":"E. Imai, M. Horio, K. Nitta, K. Yamagata, K. Iseki, Y. Tsukamoto, S. Ito, H. Makino, A. Hishida, S. Matsuo, Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am. J. Kidney Dis. 50(6), 927\u2013937 (2007)","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"2401_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00198-018-4688-1","volume":"30","author":"D Miyaoka","year":"2019","unstructured":"D. Miyaoka, Y. Imanishi, M. Ohara, N. Hayashi, Y. Nagata, S. Yamada, K. Mori, M. Emoto, M. Inaba, Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency. Osteoporos. Int. 30(1), 241\u2013249 (2019)","journal-title":"Osteoporos. Int."},{"issue":"12","key":"2401_CR18","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1210\/js.2019-00316","volume":"3","author":"E Castellano","year":"2019","unstructured":"E. Castellano, R. Attanasio, A. Boriano, G. Borretta, Clinical presentation of primary hyperparathyroidism in older adults. J. Endocr. Soc. 3(12), 2305\u20132312 (2019)","journal-title":"J. Endocr. Soc."},{"issue":"8","key":"2401_CR19","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1210\/jc.2006-0070","volume":"91","author":"L Gianotti","year":"2006","unstructured":"L. Gianotti, F. Tassone, F. Cesario, A. Pia, P. Razzore, G. Magro, A. Piovesan, G. Borretta, A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 91(8), 3011\u20133016 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2401_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cen.12188","volume":"79","author":"P Makras","year":"2013","unstructured":"P. Makras, S.A. Polyzos, A. Papatheodorou, P. Kokkoris, D. Chatzifotiadis, A.D. Anastasilakis, Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis. Clin. Endocrinol. 79(4), 499\u2013503 (2013)","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"2401_CR21","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1210\/jc.2014-1379","volume":"99","author":"CD Hendrickson","year":"2014","unstructured":"C.D. Hendrickson, D.J. Castro Pereira, R.J. Comi, Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation? J. Clin. Endocrinol. Metab. 99(8), 2646\u20132650 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2401_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijsu.2016.01.072","volume":"27","author":"RJ Egan","year":"2016","unstructured":"R.J. Egan, F. Dewi, R. Arkell, J. Ansell, S. Zouwail, D. Scott-Coombes, M. Stechman, Does elective parathyroidectomy for primary hyperparathyroidism affect renal function? A prospective cohort study. Int. J. Surg. 27, 138\u2013141 (2016)","journal-title":"Int. J. Surg."},{"issue":"8","key":"2401_CR23","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2015-2132","volume":"100","author":"F Tassone","year":"2015","unstructured":"F. Tassone, A. Guarnieri, E. Castellano, C. Baffoni, R. Attanasio, G. Borretta, Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 100(8), 3069\u20133073 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2401_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nefro.2018.08.007","volume":"39","author":"F Garcia-Martin","year":"2019","unstructured":"F. Garcia-Martin, S. Guadalix, F. Garcia-Boyano, N. Melon Pena, J.I. Martinez Pueyo, R. Callejas Martinez, M. Praga Terente, Does renal function improve after parathyroidectomy in primary hyperparathyroidism? Nefrologia 39(2), 160\u2013167 (2019)","journal-title":"Nefrologia"},{"issue":"7","key":"2401_CR25","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/jbmr.1613","volume":"27","author":"GA Block","year":"2012","unstructured":"G.A. Block, H.G. Bone, L. Fang, E. Lee, D. Padhi, A single-dose study of denosumab in patients with various degrees of renal impairment. J. Bone Miner. Res. 27(7), 1471\u20131479 (2012)","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"2401_CR26","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/jbmr.3821","volume":"34","author":"D Miyaoka","year":"2019","unstructured":"D. Miyaoka, M. Inaba, Y. Imanishi, N. Hayashi, M. Ohara, Y. Nagata, M. Kurajoh, S. Yamada, K. Mori, M. Emoto, Denosumab improves glomerular filtration rate in osteoporotic patients with normal kidney function by lowering serum phosphorus. J. Bone Miner. Res. 34(11), 2028\u20132035 (2019)","journal-title":"J. Bone Miner. Res."},{"key":"2401_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bone.2014.12.062","volume":"75","author":"S Di Gregorio","year":"2015","unstructured":"S. Di Gregorio, L. Del Rio, J. Rodriguez-Tolra, E. Bonel, M. Garcia, R. Winzenrieth, Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS). Bone 75, 138\u2013143 (2015)","journal-title":"Bone"},{"issue":"4","key":"2401_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00223-017-0295-y","volume":"101","author":"D Miyaoka","year":"2017","unstructured":"D. Miyaoka, Y. Imanishi, M. Ohara, N. Hayashi, Y. Nagata, S. Yamada, K. Mori, M. Emoto, M. Inaba, Effects of teriparatide and sequential minodronate on lumbar spine bone mineral density and microarchitecture in osteoporosis. Calcif Tissue Int. 101(4), 396\u2013403 (2017)","journal-title":"Calcif Tissue Int."},{"issue":"7","key":"2401_CR29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/jbmr.2480","volume":"30","author":"MS Ominsky","year":"2015","unstructured":"M.S. Ominsky, C. Libanati, Q.T. Niu, R.W. Boyce, P.J. Kostenuik, R.B. Wagman, R. Baron, D.W. Dempster, Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab. J. Bone Miner. Res. 30(7), 1280\u20131289 (2015)","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"2401_CR30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12020-016-1101-8","volume":"55","author":"C Cipriani","year":"2017","unstructured":"C. Cipriani, A. Abraham, B.C. Silva, N.E. Cusano, M.R. Rubin, D.J. McMahon, C. Zhang, D. Hans, S.J. Silverberg, J.P. Bilezikian, Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism. Endocrine 55(2), 591\u2013598 (2017)","journal-title":"Endocrine"},{"issue":"4","key":"2401_CR31","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2017-02169","volume":"103","author":"YD Tay","year":"2018","unstructured":"Y.D. Tay, N.E. Cusano, M.R. Rubin, J. Williams, B. Omeragic, J.P. Bilezikian, Trabecular bone score in obese and nonobese subjects with primary hyperparathyroidism before and after parathyroidectomy. J Clin Endocrinol. Metab. 103(4), 1512\u20131521 (2018)","journal-title":"J Clin Endocrinol. Metab."},{"issue":"3","key":"2401_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/a-0850-8679","volume":"51","author":"GA Miguel","year":"2019","unstructured":"G.A. Miguel, F.H. Carranza, J.C.R. Rodriguez, M.A. Ramos, D.L. Pablos, E.F. Herrero, G.M. Diaz-Guerra, Trabecular bone score, bone mineral density and bone markers in patients with primary hyperparathyroidism 2 years after parathyroidectomy. Horm. Metab. Res. 51(3), 186\u2013190 (2019)","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"2401_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1210\/jc.2007-1645","volume":"93","author":"IA Nakchbandi","year":"2008","unstructured":"I.A. Nakchbandi, R. Lang, B. Kinder, K.L. Insogna, The role of the receptor activator of nuclear factor-kappaB ligand\/osteoprotegerin cytokine system in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 93(3), 967\u2013973 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2401_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jbmr.1472","volume":"27","author":"M Austin","year":"2012","unstructured":"M. Austin, Y.C. Yang, E. Vittinghoff, S. Adami, S. Boonen, D.C. Bauer, G. Bianchi, M.A. Bolognese, C. Christiansen, R. Eastell, A. Grauer, F. Hawkins, D.L. Kendler, B. Oliveri, M.R. McClung, I.R. Reid, E.S. Siris, J. Zanchetta, C.A. Zerbini, C. Libanati, S.R. Cummings, F. Trial, Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J. Bone Miner. Res. 27(3), 687\u2013693 (2012)","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"2401_CR35","first-page":"640","volume":"35","author":"S Alonso","year":"2012","unstructured":"S. Alonso, E. Ferrero, M. Donat, G. Martinez, C. Vargas, M. Hidalgo, E. Moreno, The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy. J. Endocrinol. Investig. 35(7), 640\u2013644 (2012)","journal-title":"J. Endocrinol. Investig."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02401-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T20:27:24Z","timestamp":1625257644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02401-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.I. received grant support and lecture fees from Daiichi Sankyo Co., Ltd. Y.I. and M.E. received lecture fees from Daiichi Sankyo Co., Ltd. D.M., E.K., N.T., Y.N., M.K., and S.Y. have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the institutional ethics committee of Osaka City University Graduate School of Medicine (approval No. 2019-072) and conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}